These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 27128298)
1. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway. Bae JM; Kim JH; Kang GH Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298 [TBL] [Abstract][Full Text] [Related]
2. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway. Rhee YY; Kim KJ; Kang GH Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175 [TBL] [Abstract][Full Text] [Related]
3. Four molecular subtypes of colorectal cancer and their precursor lesions. Kang GH Arch Pathol Lab Med; 2011 Jun; 135(6):698-703. PubMed ID: 21631262 [TBL] [Abstract][Full Text] [Related]
4. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability. Messick CA; Kravochuck S; Church JM; Kalady MF Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma. Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors. Bae JM; Cho NY; Kim TY; Kang GH Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162 [TBL] [Abstract][Full Text] [Related]
7. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
9. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844 [TBL] [Abstract][Full Text] [Related]
10. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach. Legolvan MP; Taliano RJ; Resnick MB Hum Pathol; 2012 Aug; 43(8):1157-68. PubMed ID: 22658275 [TBL] [Abstract][Full Text] [Related]
11. Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer. Al-Temaimi RA; Jacob S; Al-Ali W; Thomas DA; Al-Mulla F J Histochem Cytochem; 2013 Sep; 61(9):627-38. PubMed ID: 23797051 [TBL] [Abstract][Full Text] [Related]
12. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway. Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422 [TBL] [Abstract][Full Text] [Related]
13. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps. Messick CA; Church J; Casey G; Kalady MF Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710 [TBL] [Abstract][Full Text] [Related]
15. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Young J; Jass JR Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382 [TBL] [Abstract][Full Text] [Related]
16. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy. Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972 [TBL] [Abstract][Full Text] [Related]
18. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934 [TBL] [Abstract][Full Text] [Related]
19. [Development of molecular-pathologic entities of colorectal cancer]. Kirchner T; Reu S Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367 [TBL] [Abstract][Full Text] [Related]